GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
110
c/insurancefights·posted 1 months ago by u/neha_rahimi

[Discussion] can we stop arguing about external review until somebody posts a number

Discussion

I have had 13 orders now and I keep a table, so here is the honest summary rather than a vibe.

Material has been consistent. Communication has not. Shipping has varied by about 10 days on nominally the same lane, which matters more in summer than in February.

The independent number came back 93.7% against a claimed 98.6%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.

Batch number is in the comments. Ask if you want the method.

157 up / 47 down77% upvoted14 commentsid b4jchy19 Jun 2026

14 comments

14 in this archive, depth 4

best — the order this archive was captured in

u/whois_wanda14 points·1 months ago

resubmission after denial requires new documentation

replysharereportpermalink
u/formulary_fighterappeals10 points·1 months ago

Did you get step therapy or outright denial?

replysharereportpermalink
u/neha_rahimiOP12 points·1 months ago

Denied for prior auth, resubmitted with formulary documentation, approved on appeal. The criteria exist, you just have to meet them.

replysharereportpermalink
u/line_bergstrom8 points·1 months ago·edited

formulary exclusions are negotiable sometimes

replysharereportpermalink
u/coring_the_stopper3 points·1 months ago

Not to be pedantic but formulary and appeal are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/adaeze_cabrera5 points·1 months ago

Small correction: the trial was 20 weeks, not 11. Does not change your point but people will quote it.

replysharereportpermalink
u/appeal_letter_al7 points·1 months ago

Every time this gets posted it hits the front page and every time someone has to re-explain it.

replysharereportpermalink
u/elin_varga7 points·1 months ago

the carve-out clause varies by employer

replysharereportpermalink
u/neha_rahimiOP5 points·1 months ago

the carve-out clause varies by employer

Adding to this: appeal is doing more work than the comment implies.

replysharereportpermalink
load more comments (1) →
u/sanne_novak3 points·1 months ago·edited

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

replysharereportpermalink
u/peak_area_peteanalytical1 point·1 months ago

Three years on this site and the questions have not changed at all.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/amara_haddad1 point·1 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/formulary_fighterMOD2 points·1 months ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.